Sildenafil in Heart Failure (SilHF); An Investigator Initiated Multinational Randomized Controlled Clinical Trial.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 May 2018
At a glance
- Drugs Sildenafil (Primary)
- Indications Chronic heart failure; Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms SilHF
- 04 May 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
- 04 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
- 19 Nov 2017 Status changed from recruiting to active, no longer recruiting.